found the synergistic antitumor effect of oncolytic influenza virus and B7-H3 immune junction inhibitor (monoclonal alpha-B7-H3 antibody (Enoxumab)) on ICI resistant lung cancer through experimental studies. Here, CD276 is linked to lung cancer.